2021 Q3 Form 10-Q Financial Statement

#000141057821000338 Filed on November 19, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3 2020 Q1
Revenue $5.272M $6.457M $3.614M
YoY Change -18.35% 42.66% -20.12%
Cost Of Revenue $3.696M $4.353M $2.960M
YoY Change -15.1% 71.94% 8.52%
Gross Profit $1.576M $2.104M $653.7K
YoY Change -25.09% 44.46% -63.61%
Gross Profit Margin 29.9% 32.58% 18.09%
Selling, General & Admin $1.357M $1.264M $1.173M
YoY Change 7.35% 11.39% -18.95%
% of Gross Profit 86.1% 60.09% 179.48%
Research & Development $97.07K $91.75K $204.7K
YoY Change 5.8% -48.08% 44.1%
% of Gross Profit 6.16% 4.36% 31.32%
Depreciation & Amortization $4.270K $2.170K $159.8K
YoY Change 96.77% -295.5% 5688.04%
% of Gross Profit 0.27% 0.1% 24.44%
Operating Expenses $1.454M $1.356M $1.378M
YoY Change 7.24% 3.38% -13.32%
Operating Profit $122.0K $748.1K -$724.3K
YoY Change -83.69% 416.47% -450.67%
Interest Expense $14.31K $22.22K -$2.768M
YoY Change -35.61% -104.63% 479.84%
% of Operating Profit 11.73% 2.97%
Other Income/Expense, Net
YoY Change
Pretax Income $107.7K $725.9K -$3.492M
YoY Change -85.16% -203.57% 1189.43%
Income Tax
% Of Pretax Income
Net Earnings $107.7K $725.8K -$3.492M
YoY Change -85.16% -698.27% 1189.45%
Net Earnings / Revenue 2.04% 11.24% -96.64%
Basic Earnings Per Share $0.05 $0.31
Diluted Earnings Per Share $0.05 $0.31 -$1.510M
COMMON SHARES
Basic Shares Outstanding 2.313M 2.313M
Diluted Shares Outstanding 2.313M 2.313M

Balance Sheet

Concept 2021 Q3 2020 Q3 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $168.6K $146.4K $93.79K
YoY Change 15.15% 270.05% -74.95%
Cash & Equivalents $168.6K $146.4K $93.79K
Short-Term Investments
Other Short-Term Assets $529.2K $162.1K $113.2K
YoY Change 226.55% 26.85% -22.07%
Inventory $4.966M $3.460M $5.124M
Prepaid Expenses $529.2K
Receivables $302.4K $21.73K $109.6K
Other Receivables $3.580M $4.602M $2.337M
Total Short-Term Assets $9.546M $8.393M $7.777M
YoY Change 13.75% -9.69% -25.13%
LONG-TERM ASSETS
Property, Plant & Equipment $97.51K $265.6K $346.5K
YoY Change -63.29% -37.57% 1632.57%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change -100.0%
Other Assets $4.000K $4.000K $4.000K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $144.0K $316.5K $399.7K
YoY Change -54.51% -95.99% -95.31%
TOTAL ASSETS
Total Short-Term Assets $9.546M $8.393M $7.777M
Total Long-Term Assets $144.0K $316.5K $399.7K
Total Assets $9.690M $8.709M $8.177M
YoY Change 11.27% -49.3% -56.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $396.4K $560.1K $772.3K
YoY Change -29.22% -90.37% 25.28%
Accrued Expenses $285.0K $514.6K $384.0K
YoY Change -44.62% -20.18% -36.33%
Deferred Revenue
YoY Change
Short-Term Debt $3.495M $1.380M $1.562M
YoY Change 153.22% 16.45% -15.66%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.852M $2.455M $2.718M
YoY Change 97.63% -67.89% -66.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $1.081M $0.00
YoY Change -100.0%
Other Long-Term Liabilities $77.78K $1.011M
YoY Change -70.45%
Total Long-Term Liabilities $0.00 $1.159M $1.011M
YoY Change -100.0% 340.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.852M $2.455M $2.718M
Total Long-Term Liabilities $0.00 $1.159M $1.011M
Total Liabilities $4.852M $3.614M $3.729M
YoY Change 34.24% -54.3% -53.58%
SHAREHOLDERS EQUITY
Retained Earnings -$8.070M
YoY Change
Common Stock $12.91M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.839M $5.095M $4.448M
YoY Change
Total Liabilities & Shareholders Equity $9.690M $8.709M $8.177M
YoY Change 11.27% -49.3% -56.75%

Cashflow Statement

Concept 2021 Q3 2020 Q3 2020 Q1
OPERATING ACTIVITIES
Net Income $107.7K $725.8K -$3.492M
YoY Change -85.16% -698.27% 1189.45%
Depreciation, Depletion And Amortization $4.270K $2.170K $159.8K
YoY Change 96.77% -295.5% 5688.04%
Cash From Operating Activities -$2.190M -$513.0K -$300.6K
YoY Change 326.94% -257.32% 220.55%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.308M 381.1K 217.0K
YoY Change 505.64% -174.71% -33.0%
NET CHANGE
Cash From Operating Activities -2.190M -513.0K -300.6K
Cash From Investing Activities
Cash From Financing Activities 2.308M 381.1K 217.0K
Net Change In Cash 118.2K -131.8K -83.55K
YoY Change -189.65% -28.36% -136.31%
FREE CASH FLOW
Cash From Operating Activities -$2.190M -$513.0K -$300.6K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
UUU
dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2312887
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
168570
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
160604
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
302427
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
653172
CY2021Q3 uuu Receivables From Employees
ReceivablesFromEmployees
5000
CY2021Q1 uuu Receivables From Employees
ReceivablesFromEmployees
5000
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q3 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
307427
CY2021Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
658172
CY2021Q3 uuu Due From Factor
DueFromFactor
3575028
CY2021Q1 uuu Due From Factor
DueFromFactor
1925291
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2312887
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2312887
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2312887
CY2021Q3 us-gaap Inventory Net
InventoryNet
4966226
CY2021Q1 us-gaap Inventory Net
InventoryNet
4181193
dei Amendment Flag
AmendmentFlag
false
us-gaap Lease Practical Expedients Package
LeasePracticalExpedientsPackage
true
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2312887
dei Document Type
DocumentType
10-Q
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-31747
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
103381
CY2021Q3 uuu Commissions And Other
CommissionsAndOther
105662
dei Entity Registrant Name
EntityRegistrantName
UNIVERSAL SECURITY INSTRUMENTS INC
CY2021Q1 uuu Commissions And Other
CommissionsAndOther
139242
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2312887
uuu Accounts Receivables Factoring Agreement Term
AccountsReceivablesFactoringAgreementTerm
P2Y
dei Entity Central Index Key
EntityCentralIndexKey
0000102109
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
529196
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4851541
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1697358
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2312887
CY2021Q1 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1081440
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-0898545
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
CY2021Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1081440
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
336699
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
dei Entity Address Address Line1
EntityAddressAddressLine1
11407 Cronhill Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite A
dei Entity Address City Or Town
EntityAddressCityOrTown
Owings Mills
dei Entity Address Country
EntityAddressCountry
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
21117
dei City Area Code
CityAreaCode
410
dei Local Phone Number
LocalPhoneNumber
363-3000
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q3 us-gaap Assets Current
AssetsCurrent
9546447
CY2021Q1 us-gaap Assets Current
AssetsCurrent
7261959
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
42481
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
44717
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
97506
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
184678
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4000
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4000
CY2021Q3 us-gaap Assets
Assets
9690434
CY2021Q1 us-gaap Assets
Assets
7495354
CY2021Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2413447
CY2021Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
18904
CY2021Q3 us-gaap Notes Payable To Bank Current
NotesPayableToBankCurrent
1081440
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
87908
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
171122
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
396426
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
509561
CY2021Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
675244
CY2021Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
755148
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1264209
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
97070
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
91750
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
91414
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
122005
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
748069
CY2021Q3 us-gaap Interest Expense
InterestExpense
14309
CY2020Q3 us-gaap Interest Expense
InterestExpense
22224
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
107696
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
725845
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2021Q3 us-gaap Revenues
Revenues
5272223
CY2020Q3 us-gaap Revenues
Revenues
6457295
CY2021Q3 uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
3696045
CY2020Q3 uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
4353267
CY2021Q3 us-gaap Gross Profit
GrossProfit
1576178
CY2020Q3 us-gaap Gross Profit
GrossProfit
2104028
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1357103
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2312887
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2312887
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
23129
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
23129
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
12885841
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
12885841
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8070077
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8192414
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
4838893
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
4716556
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9690434
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7495354
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2312887
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2312887
us-gaap Revenues
Revenues
9940221
us-gaap Revenues
Revenues
9398063
uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
7105718
uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
6216892
us-gaap Gross Profit
GrossProfit
2834503
us-gaap Gross Profit
GrossProfit
3181171
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2490242
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-78982
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
4369231
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
725845
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
5095076
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
4448213
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2250878
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
198126
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
225668
us-gaap Operating Income Loss
OperatingIncomeLoss
146135
us-gaap Operating Income Loss
OperatingIncomeLoss
704625
us-gaap Interest Expense
InterestExpense
23798
us-gaap Interest Expense
InterestExpense
57762
us-gaap Net Income Loss
NetIncomeLoss
122337
us-gaap Net Income Loss
NetIncomeLoss
646863
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2312887
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2312887
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
4716556
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
14641
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
4731197
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
107696
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
4838893
us-gaap Net Income Loss
NetIncomeLoss
122337
us-gaap Net Income Loss
NetIncomeLoss
646863
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6193
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4843
uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
1298992
uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
2177349
uuu Decrease Increase In Inventories Prepaid Expenses And Other
DecreaseIncreaseInInventoriesPrepaidExpensesAndOther
977530
uuu Decrease Increase In Inventories Prepaid Expenses And Other
DecreaseIncreaseInInventoriesPrepaidExpensesAndOther
-1614722
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-238585
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
144989
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2386577
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
234068
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
2394543
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-402869
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
221400
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2394543
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-181469
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7966
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
52599
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
160604
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93794
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
168570
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
146393
us-gaap Interest Paid Net
InterestPaidNet
23798
us-gaap Interest Paid Net
InterestPaidNet
54088
uuu Non Cash Conversion Of Trade Accounts Payable To Note Payable
NonCashConversionOfTradeAccountsPayableToNotePayable
1081440
CY2020Q3 uuu Minimum Amount Of Stockholder S Equity After Reporting Loss From Operations
MinimumAmountOfStockholderSEquityAfterReportingLossFromOperations
6000000.0
CY2015Q1 uuu Percentage Of Line Of Credit Facility Maximum Borrowing Capacity Of Eligible Accounts Receivable
PercentageOfLineOfCreditFacilityMaximumBorrowingCapacityOfEligibleAccountsReceivable
0.80
CY2015Q1 uuu Percentage Of Over Advance Of Line Of Credit Facility Maximum Borrowing Capacity Of Eligible Accounts Receivable
PercentageOfOverAdvanceOfLineOfCreditFacilityMaximumBorrowingCapacityOfEligibleAccountsReceivable
1
CY2015Q1 uuu Maximum Percentage Of Over Advance Of Line Of Credit Facility Maximum Borrowing Capacity Of Eligible Accounts Receivable
MaximumPercentageOfOverAdvanceOfLineOfCreditFacilityMaximumBorrowingCapacityOfEligibleAccountsReceivable
0.50
CY2015Q1 us-gaap Line Of Credit Facility Capacity Available For Trade Purchases
LineOfCreditFacilityCapacityAvailableForTradePurchases
500000
CY2021Q3 uuu Maximum Percentage Of Over Advance Of Line Of Credit Facility Maximum Borrowing Capacity Of Eligible Accounts Receivable
MaximumPercentageOfOverAdvanceOfLineOfCreditFacilityMaximumBorrowingCapacityOfEligibleAccountsReceivable
0.50
CY2021Q3 us-gaap Line Of Credit Facility Capacity Available For Trade Purchases
LineOfCreditFacilityCapacityAvailableForTradePurchases
1500000
CY2021Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
2413000
CY2021Q3 us-gaap Line Of Credit
LineOfCredit
1889000
us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.02
CY2021Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0525
CY2021Q3 us-gaap Revenues
Revenues
5272223
CY2020Q3 us-gaap Revenues
Revenues
6457295
us-gaap Revenues
Revenues
9940221
us-gaap Revenues
Revenues
9398063
CY2021Q3 uuu Purchase Of Inventory And Other Company
PurchaseOfInventoryAndOtherCompany
244000
uuu Purchase Of Inventory And Other Company
PurchaseOfInventoryAndOtherCompany
823256
CY2020Q3 uuu Purchase Of Inventory And Other Company
PurchaseOfInventoryAndOtherCompany
119000
uuu Purchase Of Inventory And Other Company
PurchaseOfInventoryAndOtherCompany
367000
uuu Maximum Amount Outstanding
MaximumAmountOutstanding
210773
uuu Maximum Amount Outstanding
MaximumAmountOutstanding
89081
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
157000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
157000
uuu Number Of Potentially Dilutive Common Stock Equivalents
NumberOfPotentiallyDilutiveCommonStockEquivalents
0
uuu Number Of Potentially Dilutive Common Stock Equivalents
NumberOfPotentiallyDilutiveCommonStockEquivalents
0
uuu Non Cash Right Of Use Asset In Exchange For Operating Lease Liability
NonCashRightOfUseAssetInExchangeForOperatingLeaseLiability
485000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
87908
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
87908
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y6M
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.060
us-gaap Operating Lease Payments
OperatingLeasePayments
85562
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
89176
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
89176
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1268
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
87908

Files In Submission

Name View Source Status
0001410578-21-000338-index-headers.html Edgar Link pending
0001410578-21-000338-index.html Edgar Link pending
0001410578-21-000338.txt Edgar Link pending
0001410578-21-000338-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uuu-20210930.xsd Edgar Link pending
uuu-20210930x10q.htm Edgar Link pending
uuu-20210930x10q_htm.xml Edgar Link completed
uuu-20210930xex31d1.htm Edgar Link pending
uuu-20210930xex31d2.htm Edgar Link pending
uuu-20210930xex32d1.htm Edgar Link pending
uuu-20210930xex99d1.htm Edgar Link pending
uuu-20210930xex99d1001.jpg Edgar Link pending
uuu-20210930xex99d1002.jpg Edgar Link pending
uuu-20210930_cal.xml Edgar Link unprocessable
uuu-20210930_def.xml Edgar Link unprocessable
uuu-20210930_lab.xml Edgar Link unprocessable
uuu-20210930_pre.xml Edgar Link unprocessable